MUTATION AND HAPLOTYPE ANALYSIS OF THE CFTR GENE IN CYSTIC FIBROSIS FAMILIES FROM BASHKORTOSTAN
Korytina G.F., Victorova T. V., Khusnutdinova E. K. Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia
*Corresponding Author: Ph.D Korytina G. F, Prospect Oktyabrya, 69, 450054, Ufa, Russia; Tel +07(3472)355255; Fax: +07(3472)356088; E-mail: Guly_Kory@mail.ru
page: 41

RESULTS AND DISCUSSION

The distribution of the CFTR gene mutations on the 160 CF chromosomes is shown in Table 1. A total of 15 different mutations were detected.  The most frequent being delF508 (35.0%), followed  by 394delTT (3.13%), CFTRdele2,3(21kb) (1.25%), R334W (1.25%), G542X (0.62%), 2184insA (0.62%),  S1196X (0.62%), 3849+10kbT C (1.25%), W1282X (0.62%), N1303K (1.25%), I488M (0.62%),1811+12AC (1.25%), T663S (1.25%), I1226R ( 0.62%), 4005+9AC  (0.62%).  Six novel mutations (I488M, 1811+12AC, T663S, I1226R, 4005+9AC) are described for the first time.

During this study two new polymorphisms were found - 2097AC (A655A)  in 13 exon (0.62%), 3996GC (V1288V) in 20 exon  (1.88 %).

So in this screening we could only characterize 50.0%  of CF chromosomes.  In 33.75% (27/80) of patients both mutant alleles were  characterized, 32.5% (26/80) were compound  heterozygotes with one unknown  allele and 33.75% (27/80) had unknown mutations on both chromosomes.

 

Table 1.  Frequency  of CFTR gene mutations identified in CF patients from Bashkortostan

Mutations

Nucleotide  change

Exon/Intron

n

%

delF508

3bp deletion 1652/1655

10

56

35.00

394delTT

deletion of  TT  at 394

3

5

3.13

CFTRdele2,3(21kb)

deletion of  exons 2 and 3

2,3

2

1.25

R334W

C → T at1132

7

2

1.25

3849+10kbC →T

C → T in 6.2 kb EcoRI fragment  10 kb from 19

19

2

1.25

1811+12A→C

A → C at 1811+12

11

2

1.25

T663S

C → G at 2120

13

2

1.25

N1303K

C → G at 4041

21

2

1.25

2184insA

insertion of A after 2184

13

1

0.63

G542X

G → T at 1756

11

1

0.63

W1282X

G → A at 3978

20

1

0.63

4005+9A→C

A→ C  at 4005 +9

20

1

0.63

S1196X

C→ G at 3719

19

1

0.63

I1226R

T → G  at 3809

19

1

0.63

I488M

T → G  at 1596

10

1

0.63

total

 

 

80

50.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The spectrum of mutations found in Bashkortostan CF patients is significantly differed from other regions of Russia [26, 27]. In  Russia delF508 has been found on 50-60% of mutant chromosomes. Most mutations are rare and occur with a frequency lower then 1% and few have a  frequency between 1% and 5%. The level of detection of the CFTR mutations in Bashkortostan is lower than that observed in other populations with relatively low  frequency of delF508 mutation [11, 12, 15, 24]. So a high population specificity of the CFTR mutation spectrum and frequencies has been observed in different regions of Russia.

 a comparative analysis of the allele frequency distributions on normal and mutant chromosomes was carried out for five intragenic CFTR markers. The data on allele frequency distribution patterns are presented in Table 2.

Based on the data on the CFTR markers allele and genotype frequency distributions, a comparative analysis of the two SNP (M470V, TUB20)  and three STR  (IVS6aGATT, IVS8CA and IVS17CA) DNA markers  haplotype frequency distributions was carried out.

Haplotype phases could establish for 169 normal, 26 delF508, and 20 chromosomes carrying other   different CFTR  mutations  and  52 chromosomes with unknown CFTR mutations.

Two diallelic  haplotypes M470V-TUB20  2-2  (28.4%) and 1-2 (30.2%) accounted for 58.6% of all normal chromosomes. Analysis of the M470V-TUB20-IVS6aGATT-IVS8CA-IVS17CA haplotypes on 169 normal chromosomes revealed the presence of 52 haplotypes (Table 3). Haplotype distribution on normal chromosomes was characterized by high degree of dispersion, which was confirmed by the high level of haplotype diversity (h=0.961). Fifteen haplotypes occurred with the frequency higher than 2% each, and only  five of them  had  the frequency greater than 5% (Table 2). The frequency of the 2-2-7-7-7 haplotype, which is most common on normal chromosomes, did not exceed 11.0%, which is consistent with the data for the European populations [27, 28].

 

Table 2. Allele frequencies of CFTR gene intragenic markers  on mutant and normal chromosomes

 

Locus, allele
(repeat)

Chromosomes

Mutant

(frequency/n)

Mutant with delF508
(frequency/n)

Mutant without delF508
(frequency/n)

Normal

(frequency/n)

M470V

1
2

 

0,59 (68)
0,41 (48)

 

0,97 (30)
0,03 (1)

 

0,45 (38)
0,55 (47)

 

0,48 (57)
0,52 (63)

TUB20

1
2

 

0,27 (31)
0,73 (83)

 

0,14 (4)
0,86 (25)

 

0,32 (27)
0,68 (58)

 

0,46 (51)
0,54 (59)

IVS6aGATT

(6)
(7)
(8)

 

0,47 (49)
0,52 (54)
0,01 (1)

 

1,00 (22)
0,00
0,00

 

0,33 (27)
0,66 (54)
0,01 (1)

 

0,26 (32)
0,72 (90)
0,02 (2)

IVS8CA

1 - (24)
2 - (23)
3 - (22)
4 - (21)
5 - (18)
6 - (17)
7 - (16)
8 - (15)

 

0,01 (1)
0,18 (20)
0,02 (2)
0,00
0,02 (2)
0,35 (37)
0,39 (41)
0,03 (3)

 

0,00
0,44 (11)
0,00
0,00
0,04 (1)
0,52 (13)
0,00
0,00

 

0,01 (1)
0,11 (9)
0,03 (2)
0,00
0,01 (1)
0,29 (24)
0,51 (41)
0,04 (3)

 

0,01 (1)
0,02 (2)
0,00
0,00
0,02 (2)
0,34 (41)
0,51 (61)
0,10 (13)

IVS17CA

1 - (19)
2 - (18)
3 - (17)
4 - (16)
5 - (15)
6 - (14)
7 - (13)

8 - (11)

 

0,00
0,01 (1)
0,10 (11)
0,00
0,00
0,01 (1)
0,85 (88)
0,03 (3)

 

0,00
0,00
0,00
0,00
0,00
0,00
1,00  (23)
0,00

 

0,00
0,01 (1)
0,14 (11)
0,00
0,00
0,01 (1)
0,80 (65)
0,04 (3)

 

0,00
0,00
0,14 (20)
0,01 (1)
0,01 (1)
0,00
0,78 (110)
0,06 (8)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 3.  CFTR haplotypes for two SNP (M470V, TUB20),  and three STR  (IVS6aGATT, IVS8CA and IVS17CA) DNA markers  on    normal chromosomes

 

?

Haplotypes

n

%

M470V-TUB20

IVS6aGATT-IVS8CA-IVS17CA

1

2-2

7-7-7

18

10.65

2

1-2

7-7-7

15

8.88

3

1-1

7-7-7

12

7.11

4

1-2

6-6-7

10

5.92

5

2-1

7-7-7

9

5.33

6

2-2

7-6-7

8

4.73

7

2-1

7-6-7

7

4.14

8

1-1

7-7-3

6

3.56

9

1-1

7-6-7

6

3.56

10

1-1

6-6-7

6

3.56

11

2-2

6-7-7

5

2.96

12

1-2

7-6-7

5

2.96

13

1-2

6-7-7

5

2.96

14

2-1

7-8-7

4

2.37

15

1-1

6-7-7

4

2.37

16

2-1

7-7-3

3

1.78

17

1-2

7-7-3

3

1.78

18

2-1

7-2-7

3

1.78

19

2-1

6-6-7

2

1.18

20

2-2

6-2-7

2

1.18

21

1-1

7-8-7

2

1.18

22

2-1

7-8-7

2

1.18

23

2-1

6-8-7

2

1.18

24

1-1

7-6-8

2

1.18

 

 All uncommon haplotypes (with frequency  < 1%, on 1 chromosome)

28

16.57

 

Table 4.  CFTR haplotypes for two SNP (M470V, TUB20)  and three STR  (IVS6aGATT, IVS8CA and IVS17CA) DNA markers  on  CF chromosomes  bearing  delF508  and other   different CF  mutations

 

mutation

haplotypes

n

%

SNP

STR

M470V-TUB20

IVS6aGATT-IVS8CA-IVS17CA

CF chromosomes  with delF508 (n=26)

delF508

1-2
1-2
1-2
1-1
1-1
2-1

6-6-7
6-2-7
6-5-7
6-6-7
6-2-7
6-2-7

13
9
1
1
1
1

50.00
34.61
3.84
3.84
3.84
3.84

CF chromosomes  with other   different CFTR  mutations  (n=20)

3849+10kbT →C
W1282X
T663S

1-2

7-7-7

3

15.00

R334W

2-2

7-6-7

2

10.00

2184insA

1-1

7-7-3

1

5.00

N1303K

1-1

7-6-7

1

5.00

T663S

2-1

6-6-7

1

5.00

CFTRdele2,3(21kb)

2-1

7-7-7

1

5.00

G542X
4005+9A →C

1-2

6-6-7

2

10.00

394delTT

1-2

6-2-7

2

10.00

CFTRdele2,3(21kb)
1811+12A →C

2-2

7-7-7

2

10.00

3849+10kbC →T

2-2

6-6-3

1

5.00

1811+12A →C

2-1

7-7-8

1

5.00

N1303K

1-2

8-6-7

1

5.00

S1196X

1-1

7-8-7

1

5.00

I1226R

1-1

6-2-7

1

5.00

 

 

The delF508 mutation was presented on three  different M470V-TUB20 diallelic haplotypes, with the combination 1-2 accounting for 88.45% of all delF508 alleles (Table 4). One haplotype 1-1 could derive from the original by recombination and another one 2-1 derived from the 1-1 haplotype by a point mutation at the polymorphic  loci (M470V) or by recombination. Our results are in agreement with previous  data, which suggested  a single origin of the  delF508 mutation [27], because  delF508 arose from ancestral chromosome  with haplotype 1-2, which is uncommon in the actual background of normal chromosomes (30.2%) (c2=30.07, p<0.0005).

 Only three microsatellite IVS6aGATT-IVS8CA-IVS17CA haplotypes were found associated with delF508 and two of them 6-6-7 and 6-2-7 were common, 53.84% and 42.29%, respectively. Six different M470V-TUB20-IVS6aGATT-IVS8CA-IVS17CA haplotypes were discovered on delF508 chromosomes, two of them being most frequent. These were haplotypes 1-2-6-6-7 and 1-2-6-2-7 found with the frequencies of 50.00% and 35.00%, respectively. According to the hypothesis of Morral et al. [20], the association of two different haplotypes with one mutation is explained either by the replication error, like slipped-strand mispairing (slippage of the polymerase over the repeat sequence during the replication), or by crossingover error, which has arisen after the appearance of the delF508 mutation, resulting in the distribution of the 1-2-6-6-7 haplotype. It can be suggested that mutant chromosomes with the 1-2-6-6-7 and 1-2-6-2-7 haplotypes have already existed at that time, but their distribution was independent. Probably, because of this, in the regions, like Russia and Northern, and Central Europe, the 1-2-6-6-7 haplotype prevails, while in the Mediterranean countries the 1-2-6-2-7  haplotype is most frequent. Taking into consideration the prevalence of the 1-2-6-6-7  haplotype in CF patients from Russia, it can be suggested that delF508 chromosomes with this haplotype first appeared in Russia, and there were preferentially distributed as compared to the delF508 chromosomes with the 1-2-6-2-7  haplotype.

Our results suggest that the appearance of the delF508 mutation in the gene pool of Bashkortostan was associated with the migrations of the Slavic populations from the Eastern Europe.

            The other frequent mutation in our population  was 394delTT, and two  CF chromosomes with this mutation share the same haplotype 1-2-6-2-7, which  is also the same haplotype in which the delF508 arose (Table 2.).

Two chromosomes with  R334W were associated with  same haplotype 2-2-7-6-7, our results support  single origin of this  chromosomes in our CF population.

            Both chromosomes with mutation CFTRdele2,3(21kb) were  associated with same microsatellite haplotype 7-7-7. Two different diallelic haplotype associated with CFTRdele2,3(21kb) might be explained by recombination. Our results are in agreement with previous  data which suggested  a single Slavic origin of the CFTRdele2,3(21kb) mutation [29].  

The most common microsatellite haplotype on normal chromosomes 7-7-7 are associated with the largest number  of mutations (6).

One  CF chromosome with 3849+10kbT C were detected on haplotype 2-2-6-6-3, which did not present on normal chromosomes.

             Several mutations are associated with several haplotypes, as a result of slippage or  recombination.

            Table  5. lists the CFTR haplotypes for  52  CF chromosomes with unknown mutations.  Analysis of the M470V-TUB20-IVS6aGATT-IVS8CA-IVS17CA haplotypes on CF chromosomes with unknown mutations showed that the 2-2-7-7-7 haplotype was most frequent (26.9%). The differences between these and normal chromosomes were statistically significant (c2=7.24, p<0.008). It seems likely that CF patients from Bashkortostan, mostly belonging to the Turkic-speaking families, possess specific CFTR gene defect associated with the given haplotype. 

In general, on 52 mutant chromosomes with unknown mutations, a total of 30 different haplotypes were discovered with 38% of these not detected on normal chromosomes. The different haplotypes found suggest that most of this unknown CF alleles  carry different mutations, further confirming the high heterogeneity of Bashkortostan CF population.

Intragenic polymorphic markers seem most promising to be used as diagnostic markers.  To assess the possibility of utilization of the M470V, TUB20, IVS6aGATT, IVS8CA, and IVS17CA polymorphic systems for the DNA diagnostics of CF, the CF families were examined for the levels of heterozygosity relative these loci. These values constituted 48% for M470V, 46% for TUB20, 50% for IVS6aGATT, 91% for IVS8CA, and 24% IVS17CA. Analysis of the IVS6aGATT-IVS8CA-M470V-IVS17CA-TUB20 haplotypes makes it possible to increase the proportion of completely informative families up to 88%. Therefore, we conclude that the CFTR polymorphic markers examined are highly valuable for the family analysis and prenatal diagnostics of CF in Bashkortostan.

            The CFTR gene analysis confirmed the high heterogeneity of our CF population, which could be explained by the complex ethnic composition of the Bashkortostan population, resulting from the mixing of  different ethnical genetic pools ((European and Asian).

 

 

 

Table 5.  CFTR haplotypes for two SNP (M470V, TUB20)  and three STR  (IVS6aGATT, IVS8CA and IVS17CA) DNA markers  on   52 CF chromosomes  with unknown CFTR mutations

 

?

haplotypes

n

%

M470V-TUB20

IVS6aGATT-IVS8CA-IVS17CA

1

2-2

7-7-7

14

26.90

2

1-1

7-7-3

3

5.77

3

2-2

6-7-7

3

5.77

4

1-2

7-7-7

2

3.85

5

2-2

7-6-7

2

3.85

6

1-1

7-6-7

2

3.85

7

2-1

7-6-7

2

3.85

8

1-1

6-6-7

2

3.85

All uncommon haplotypes (with frequency  < 2%,
on 1 chromosome)

22

43.70

 




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006